Horizon Discovery Group Signs Co-Exclusive Commercial Agreement with Haplogen Genomics
October 6, 2014
Cambridge, UK -- Horizon Discovery Group plc (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has entered a worldwide co-exclusive distribution agreement with Haplogen Genomics GmbH (Haplogen). The agreement provides Horizon with access to a new high-throughput, affordable cell line engineering service. [...]
American Peptide Company and GlyTech, Inc. Announce Co-promotion Agreement
October 6, 2014
Vista, CA -- American Peptide Company, Inc. (APC) (Vista, CA) a leading peptide manufacturer, and GlyTech Inc. (Kyoto, Japan), a world-leading developer of glycosylated drugs, announced today that they have entered into a co-promotion agreement for GlyTech’s glycosylation technology. As part of the agreement, APC will leverage its sales and marketing resources to enhance GlyTech’s [...]
PerkinElmer Launches New AlphaLISA® SureFire® Ultra Assays
October 6, 2014
WHAT:PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of its AlphaLISA® SureFire® Ultra™ assays. These solutions are designed to reduce assay time by up to 50 percent and to improve the protein phosphorylation detection process. This is critical for helping life science professionals [...]
October 6, 2014
ALAMEDA, Calif. -– LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of GeneAnalytics 1.0 atwww.geneanalytics.com. GeneAnalytics™ is a powerful, yet easy to use, gene set analysis tool designed to help life scientists and biomedical researchers identify expression signatures and functionality of their experimental gene sets, and define their roles in [...]
AxioMx Inc. Develops Novel Synthetic Antibody Library
October 6, 2014
Branford, Conn. -- AxioMx Inc., a leader in recombinant antibody technologies, today announced the successful completion of research funded by a National Institute of Health (NIH) SBIR grant to develop a novel library for selection of affinity reagents. Under the research, AxioMx created a highly diverse synthetic phage-display antibody library. “We are refining the affinity [...]
Phenomenex Introduces First Synthetic Sorbent for Simplified Liquid Extraction (SLE)
October 6, 2014
Torrance, CA -– Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Novum Simplified Liquid Extraction (SLE), a novel, synthetic alternative to traditional diatomaceous earth SLE (also known as supported liquid extraction) products and a simplified approach to traditional liquid-liquid extraction (LLE). Extraction techniques used prior [...]
LabVantage Solutions Launches a New Major Version of its LIMS
October 6, 2014
Somerset, NJ –– LabVantage Solutions announced the immediate availability of LabVantage 7 at its annual user conference. LabVantage 7 provides significantly improved user experience as well as capabilities that make it easier to enable process optimization. LabVantage 7 was built with extensive customer feedback that was backed up by a beta testing program. LabVantage 7 [...]
BioTime, Inc. and Subsidiaries to Raise $31 Million Through Sales of Common Shares
October 6, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT:BTX) today announced that it has agreed to sell up to an aggregate of 9,431,398 common shares, in a registered direct offering at an offering price of $3.12 per share. The price per share was the closing price of our common shares on the NYSE MKT on October 2, [...]
BIOFORCE NANOSCIENCES, INC. BEGINS SALES OF THEIR NEW NANO ENABLER
October 6, 2014
CHICAGO, IL -– BioForce Nanosciences, Inc. (BioForce) recently completed the installation of the newest version of its groundbreaking Nano eNabler Benchtop Molecular Printer. With increased optical resolution, state of the art computer hardware and Windows 8.1 operating system, the Nano eNabler will provide expanded capabilities for the research market. The Nano eNabler is the only [...]
October 6, 2014
Qbic Arkiv Fund, Foundation Majoie and SOFI invest 2.0 million EUR in UGent spin-off Biogazelle, a company that offers software and laboratory services for gene expression analysis. Biogazelle will primarily use the investment to further develop its research on therapeutic RNA targets for specific cancer types, and to expand its commercial activities. Biogazelle (www.biogazelle.com) was [...]

